Related Experiment Video

Updated: May 10, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 19, 2013

Gene-based therapy in prostate cancer

Ruth Foley1, Mark Lawler, Donal Hollywood

  • 1Department of Haematology and Oncology, Institute of Molecular Medicine, St James' Hospital and Trinity College, Dublin, Ireland.

The Lancet. Oncology
|August 4, 2004
PubMed

Insights

Gene therapy shows promise as an effective addition to conventional prostate cancer treatments. Research focuses on targeted gene delivery and expression within prostate tissue for improved outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Prostate cancer is a leading cause of cancer-related morbidity and mortality.
  • Conventional treatments include radical prostatectomy, radiotherapy, and hormonal therapy.
  • Gene therapy is emerging as a potential adjuvant treatment strategy.

Purpose of the Study:

  • To review and evaluate various gene therapy approaches for prostate cancer.
  • To describe methods of gene delivery relevant to prostate cancer research.
  • To discuss strategies for achieving tissue-specific gene delivery and expression.

Main Methods:

  • Review of existing literature on gene therapy for prostate cancer.
  • Description of common gene delivery methods used in prostate cancer research.
  • Analysis of tissue-specific gene promoters for targeted delivery.

Main Results:

  • Several gene therapy strategies have been investigated for prostate cancer.
  • Tissue-specific promoters are crucial for targeted gene delivery to prostate tissue.
  • Direct delivery of gene-therapy vectors to prostate tissue is feasible.

Conclusions:

  • Gene therapy holds significant promise as an adjuvant treatment for prostate cancer.
  • Targeted gene delivery and tissue-specific gene expression are key to successful application.
  • Ongoing clinical trials are evaluating the efficacy of gene therapy in prostate cancer management.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...